bottle of semaglutide Flex-Dose 4 mL Injectable 2.5 mg/mL Compound Semaglutide

Y.BillingL.SkeffingtonK.SewingS.ReimannF.et al (2015)

Retrieved from We regularly update the articles on ChoosingTherapy.com to ensure we continue to reflect scientific consensus on the topics we cover, to incorporate new research into our articles, and to better answer our audiences questions

Generally mild and reversible with dose reduction or discontinuation

A Brief History of GH Secretagogues The GH secretagogue story begins in the 1970s when Cyril Bowers discovered that small synthetic peptides based on enkephalin could release GH from pituitary cells without acting through opioid receptors

(PubMed) Yang J, Wang T, Yang J, et al